COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U Niemann; Farrukh T Awan; Laura Fogliatto; Eugene Nikitin; Olga Samoilova; Adel Habib; Kayhan Foroutanpour; Nataliya Kuptsova-Clarkson; Stephen Opat

doi:10.1097/HS9.0000000000000780

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

Carsten U Niemann^*, Farrukh T Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson, Stephen Opat

^*Corresponding author af dette arbejde

Afdeling for Blodsygdomme CKO

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	HemaSphere
Vol/bind	6
Udgave nummer	10
Sider (fra-til)	e780
ISSN	2572-9241
DOI	https://doi.org/10.1097/HS9.0000000000000780
Status	Udgivet - okt. 2022

Adgang til dokumentet

10.1097/HS9.0000000000000780

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{128ef24b833a434b88f10983feab8789,

title = "COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study",

author = "Niemann, {Carsten U} and Awan, {Farrukh T} and Laura Fogliatto and Eugene Nikitin and Olga Samoilova and Adel Habib and Kayhan Foroutanpour and Nataliya Kuptsova-Clarkson and Stephen Opat",

year = "2022",

month = oct,

doi = "10.1097/HS9.0000000000000780",

language = "English",

volume = "6",

pages = "e780",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

AU - Niemann, Carsten U

AU - Awan, Farrukh T

AU - Fogliatto, Laura

AU - Nikitin, Eugene

AU - Samoilova, Olga

AU - Habib, Adel

AU - Foroutanpour, Kayhan

AU - Kuptsova-Clarkson, Nataliya

AU - Opat, Stephen

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85148937657&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000780

DO - 10.1097/HS9.0000000000000780

M3 - Letter

C2 - 36168519

SN - 2572-9241

VL - 6

SP - e780

JO - HemaSphere

JF - HemaSphere

IS - 10

ER -